BiotechTubeBiotechTube
Home/Crinetics Pharmaceuticals/John Newell-Price, M.D., Ph.D.
JN

John Newell-Price, M.D., Ph.D.

Scientific Advisory Board Member

Crinetics Pharmaceuticals

Therapeutic Areas

EndocrinologyRare DiseasesOncology (Endocrine-related Tumors)

Crinetics Pharmaceuticals Pipeline

DrugIndicationPhase
Paltusotine (CRN00808)AcromegalyPhase 3
CRN04894Cushing's DiseasePhase 2
CRN04777HyperinsulinismPhase 1
CRN01941Neuroendocrine Tumors (NETs)Preclinical

Leadership Team at Crinetics Pharmaceuticals

RS
R. Scott Struthers, Ph.D.
Founder & Chief Executive Officer
SF
Stephen F. Betz, Ph.D.
Founder & Chief Scientific Officer
GA
Garlan Adams, J.D.
Chief Legal Officer
AC
Adriana C. Cabré
Chief Human Resources Officer
OH
Omar Hamdy, Ph.D.
Senior Vice President, Chief of Staff & Head of Portfolio Strategy
IK
Isabel Kalofonos
Chief Commercial Officer
JK
Jacqueline Kirby
Chief Corporate Affairs Officer
JK
Jeff Knight, M.P.H.
Chief Development & Operating Officer
AS
Alan S. Krasner, M.D.
Chief Endocrinologist
CR
Chris Robillard
Chief Business Officer
View full Crinetics Pharmaceuticals profile